Latest news with #Reinberg
Business Insider
20-07-2025
- Business
- Business Insider
Kepler Capital Sticks to Its Hold Rating for Getinge (0GZV)
Kepler Capital analyst Oliver Reinberg maintained a Hold rating on Getinge on July 18 and set a price target of SEK225.00. The company's shares closed last Friday at SEK201.91. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. Reinberg covers the Healthcare sector, focusing on stocks such as STRATEC Biomedical, Koninklijke Philips N.V., and Fresenius Medical Care AG & Co. KGaA. According to TipRanks, Reinberg has an average return of -5.5% and a 40.90% success rate on recommended stocks. Currently, the analyst consensus on Getinge is a Hold with an average price target of SEK211.67, which is a 4.83% upside from current levels. In a report released on July 18, TR | OpenAI – 4o also reiterated a Hold rating on the stock with a SEK203.00 price target. The company has a one-year high of SEK232.20 and a one-year low of SEK164.55. Currently, Getinge has an average volume of 188.9K.
Business Insider
16-07-2025
- Business
- Business Insider
Draegerwerk AG & Co. KGaA (0K5E) Gets a Buy from Kepler Capital
In a report released on July 14, Oliver Reinberg from Kepler Capital maintained a Buy rating on Draegerwerk AG & Co. KGaA, with a price target of €85.00. The company's shares closed last Monday at €69.20. Elevate Your Investing Strategy: Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week. According to TipRanks, Reinberg is an analyst with an average return of -5.4% and a 40.99% success rate. Reinberg covers the Healthcare sector, focusing on stocks such as Fresenius Medical Care AG & Co. KGaA, Fresenius SE & Co. KGaA, and STRATEC Biomedical. Draegerwerk AG & Co. KGaA has an analyst consensus of Moderate Buy, with a price target consensus of €82.67, a 19.47% upside from current levels. In a report released on July 14, Warburg Research also maintained a Buy rating on the stock with a €85.00 price target. Based on Draegerwerk AG & Co. KGaA's latest earnings release for the quarter ending December 31, the company reported a quarterly revenue of €1.08 billion and a net profit of €76.03 million. In comparison, last year the company earned a revenue of €1.05 billion and had a net profit of €65.06 million
Business Insider
27-06-2025
- Business
- Business Insider
Kepler Capital Sticks to Its Hold Rating for Carl Zeiss Meditec (0DHC)
In a report released on June 25, Oliver Reinberg from Kepler Capital maintained a Hold rating on Carl Zeiss Meditec (0DHC – Research Report), with a price target of €59.00. The company's shares closed last Wednesday at €57.65. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Reinberg is an analyst with an average return of -5.5% and a 40.82% success rate. Reinberg covers the Healthcare sector, focusing on stocks such as Carl Zeiss Meditec, Draegerwerk AG & Co. KGaA, and Fresenius Medical Care AG & Co. KGaA. Carl Zeiss Meditec has an analyst consensus of Hold, with a price target consensus of €64.17.
Business Insider
19-06-2025
- Business
- Business Insider
Kepler Capital Sticks to Their Hold Rating for Fresenius Medical Care AG & Co. KGaA (0H9X)
Kepler Capital analyst Oliver Reinberg maintained a Hold rating on Fresenius Medical Care AG & Co. KGaA (0H9X – Research Report) on June 17 and set a price target of €49.00. The company's shares closed last Tuesday at €47.28. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Reinberg covers the Healthcare sector, focusing on stocks such as Draegerwerk AG & Co. KGaA, Fresenius Medical Care AG & Co. KGaA, and Fresenius SE & Co. KGaA. According to TipRanks, Reinberg has an average return of -5.7% and a 40.60% success rate on recommended stocks. Fresenius Medical Care AG & Co. KGaA has an analyst consensus of Hold, with a price target consensus of €49.25, which is a 4.17% upside from current levels. In a report released yesterday, Bernstein also maintained a Hold rating on the stock with a €54.50 price target.
Business Insider
30-05-2025
- Business
- Business Insider
Kepler Capital Reaffirms Their Hold Rating on Elekta AB (0O5H)
Kepler Capital analyst Oliver Reinberg maintained a Hold rating on Elekta AB (0O5H – Research Report) on May 28 and set a price target of SEK64.00. The company's shares closed last Wednesday at SEK52.65. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter According to TipRanks, Reinberg is an analyst with an average return of -5.2% and a 40.69% success rate. Reinberg covers the Healthcare sector, focusing on stocks such as Fresenius SE & Co. KGaA, Draegerwerk AG & Co. KGaA, and Fresenius Medical Care AG & Co. KGaA. In addition to Kepler Capital , Elekta AB also received a Hold from Danske Bank's Erik Cassel in a report issued on May 21. However, yesterday, Barclays maintained a Sell rating on Elekta AB (LSE: 0O5H).
